Ruck A, Kendall D A, Hill S J
Department of Physiology and Pharmacology, Medical School, Queens Medical Centre, Nottingham, U.K.
Biochem Pharmacol. 1991 Jun 21;42(1):59-69. doi: 10.1016/0006-2952(91)90681-t.
The effect of noradrenaline and isoprenaline on cyclic AMP accumulation has been investigated in primary rat astrocytes which contain either (a) protoplasmic astrocytes alone or (b) both fibrous and protoplasmic astrocytes. Isoprenaline and noradrenaline stimulated cyclic AMP formation in both astrocyte culture preparations. Combinations of noradrenaline (1 microM) and isoprenaline (1 microM) produced a cyclic AMP response which was 58% and 26% of that produced by isoprenaline alone in protoplasmic and mixed fibrous/protoplasmic cultures, respectively. In both preparations this inhibitory effect of noradrenaline was antagonized by the alpha 2-adrenoceptor antagonist yohimbine (1 microM). A striking feature of the concentration-response curve for isoprenaline (EC50 = 0.8 microM) in mixed fibrous/protoplasmic cultures was that the cyclic AMP response decreased sharply at concentrations above 1 microM. This phenomenon was not seen in cultures containing protoplasmic astroglia alone. The fall in the isoprenaline concentration-response curve was not observed in the presence of the alpha-adrenoceptor antagonist phentolamine (1 microM), the dihydropyridine calcium antagonist isradipine (10 microM), the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (0.1 mM) or in nominally calcium-free medium. The effect of phentolamine was mimicked by the alpha 1-adrenoceptor antagonist prazosin (1 microM) but not by the alpha 2-antagonist yohimbine (1 microM). In conclusion, the data from this study suggest that two different populations of astrocytes in in vitro culture are able to raise intracellular cyclic AMP levels via beta-adrenoceptor activation and that there are differences in the extent of alpha-adrenoceptor (both alpha 1- and alpha 2-) mediated inhibition of cyclic AMP accumulation between the two primary astroglial cell preparations.
已在原代大鼠星形胶质细胞中研究了去甲肾上腺素和异丙肾上腺素对环磷酸腺苷(cAMP)积累的影响,这些原代大鼠星形胶质细胞包含:(a)仅含原浆性星形胶质细胞,或(b)同时含纤维性和原浆性星形胶质细胞。异丙肾上腺素和去甲肾上腺素在两种星形胶质细胞培养制剂中均刺激了cAMP的形成。在原浆性培养物以及混合的纤维性/原浆性培养物中,去甲肾上腺素(1微摩尔/升)和异丙肾上腺素(1微摩尔/升)的组合所产生的cAMP反应分别为单独使用异丙肾上腺素时所产生反应的58%和26%。在这两种制剂中,去甲肾上腺素的这种抑制作用均被α2 -肾上腺素能受体拮抗剂育亨宾(1微摩尔/升)所拮抗。在混合的纤维性/原浆性培养物中,异丙肾上腺素浓度 - 反应曲线(EC50 = 0.8微摩尔/升)的一个显著特征是,在浓度高于1微摩尔/升时,cAMP反应急剧下降。在仅含原浆性星形胶质细胞的培养物中未观察到这种现象。在存在α -肾上腺素能受体拮抗剂酚妥拉明(1微摩尔/升)、二氢吡啶类钙拮抗剂伊拉地平(10微摩尔/升)、磷酸二酯酶抑制剂3 -异丁基 - 1 -甲基黄嘌呤(0.1毫摩尔/升)的情况下,或在名义上无钙的培养基中,均未观察到异丙肾上腺素浓度 - 反应曲线的下降。酚妥拉明的作用被α1 -肾上腺素能受体拮抗剂哌唑嗪(1微摩尔/升)模拟,但未被α2 -拮抗剂育亨宾(1微摩尔/升)模拟。总之,本研究的数据表明,体外培养的两种不同类型的星形胶质细胞能够通过β -肾上腺素能受体激活来提高细胞内cAMP水平,并且在两种原代星形胶质细胞制剂之间,α -肾上腺素能受体(α1和α2)介导的对cAMP积累的抑制程度存在差异。